Farallon Capital Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $428M | Buy |
|
|||||
|
2025
Q1 | $380M | Sell |
|
|||||
|
2024
Q4 | $449M | Sell |
|
|||||
|
2024
Q3 | $455M | Buy |
|
|||||
|
2024
Q2 | $316M | Sell |
|
|||||
|
2024
Q1 | $315M | Sell |
|
|||||
|
2023
Q4 | $336M | Buy |
|
|||||
|
2023
Q3 | $266M | Sell |
|
|||||
|
2023
Q2 | $273M | Sell |
|
|||||
|
2023
Q1 | $385M | Sell |
|
|||||
|
2022
Q4 | $428M | Sell |
|
|||||
|
2022
Q3 | $471M | Sell |
|
|||||
|
2022
Q2 | $561M | Sell |
|
|||||
|
2022
Q1 | $697M | Sell |
|
|||||
|
2021
Q4 | $714M | Buy |
|
|||||
|
2021
Q3 | $608M | Buy |
|
|||||
|
2021
Q2 | $544M | Sell |
|
|||||
|
2021
Q1 | $496M | Sell |
|
|||||
|
2020
Q4 | $476M | Buy |
|
|||||
|
2020
Q3 | $316M | Buy |
|